More tools:Markets·Screener·Research·Chat

Zimmer Biomet Holdings, Inc. (ZBH) Financial Statements

Zimmer Biomet Holdings, Inc.
SIC 3842 · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
FIGI BBG001S7DQJ9
XNYS · usd
91.62▼ 2.99 (-3.16%)
As of 2026-09-10
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close94.61
Day's Range92.55 – 95.73
52-Week Range79.12 – 106.88
Volume2.0M
Avg Volume2.1M
Share Statistics
Shares Outstanding
Employees17.0K
ExchangeXNYS
Listed2001-08-07
Share count as of July 30, 2026
Loading Income Statement…
Key questions about Zimmer Biomet Holdings, Inc. (ZBH)
What is Zimmer Biomet Holdings, Inc.'s Market Cap?
Zimmer Biomet Holdings, Inc.'s Market Cap is $17.5B, based on as-reported figures from SEC (XBRL) filings.
What is Zimmer Biomet Holdings, Inc.'s Enterprise Value?
Zimmer Biomet Holdings, Inc.'s Enterprise Value is $24.5B, based on as-reported figures from SEC (XBRL) filings.
What is Zimmer Biomet Holdings, Inc.'s Trailing P/E?
Zimmer Biomet Holdings, Inc.'s Trailing P/E is 21.7×, based on as-reported figures from SEC (XBRL) filings.
What is Zimmer Biomet Holdings, Inc.'s Price / Sales?
Zimmer Biomet Holdings, Inc.'s Price / Sales is 2.1×, based on as-reported figures from SEC (XBRL) filings.
What is Zimmer Biomet Holdings, Inc.'s EV / Revenue?
Zimmer Biomet Holdings, Inc.'s EV / Revenue is 2.9×, based on as-reported figures from SEC (XBRL) filings.
What is Zimmer Biomet Holdings, Inc.'s EV / EBITDA?
Zimmer Biomet Holdings, Inc.'s EV / EBITDA is 10.9×, based on as-reported figures from SEC (XBRL) filings.
What is Zimmer Biomet Holdings, Inc.'s Revenue (TTM)?
Zimmer Biomet Holdings, Inc.'s Revenue (TTM) is $8.5B, based on as-reported figures from SEC (XBRL) filings.
What is Zimmer Biomet Holdings, Inc.'s Net Income (TTM)?
Zimmer Biomet Holdings, Inc.'s Net Income (TTM) is $806.7M, based on as-reported figures from SEC (XBRL) filings.
What is Zimmer Biomet Holdings, Inc.'s EBITDA?
Zimmer Biomet Holdings, Inc.'s EBITDA is $2.3B, based on as-reported figures from SEC (XBRL) filings.
What is Zimmer Biomet Holdings, Inc.'s Diluted EPS (TTM)?
Zimmer Biomet Holdings, Inc.'s Diluted EPS (TTM) is 4.23, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Net Sales
YoY growth+4.8%+9.3%+10.9%+9.7%
Cost of products sold, excluding intangible asset amortization
Intangible asset amortization
Research and development
Selling, general and administrative
Restructuring and other cost reduction initiatives
Acquisition, integration, divestiture and related
Operating expenses
% of revenue85.0%82.1%93.1%82.4%
Operating Profit
% of revenue15.0%17.9%6.9%17.6%
Other income (expense), net
Interest expense, net
Earnings before income taxes
Provision for income taxes
Net Earnings
Less: Net earnings attributable to noncontrolling interest
Net Earnings of Zimmer Biomet Holdings, Inc.
% of revenue9.1%11.4%6.2%11.5%
Earnings Per Common Share
Basic
Diluted